🔎 Trials Near Me

Akèy › Maladi otoim › Oregon

Etid klinik pou Maladi otoim nan Oregon

9 etid pou Maladi otoim ap chèche patisipan nan sit nan Oregon.

Vil nan Oregon

Tèks ofisyèl etid la (Anglè)

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  • Oregon Health & Science University, Portland
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT06722235

RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

  • Oregon Health & Science University - Accepting Adult Patients, Portland
Ap rekriteFaz 2/3
Laj 6 a 75 · Tout sèks · Mizajou Sep 17, 2026 · NCT06154252

A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  • Oregon Health & Science University, Portland
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06948318

RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis

  • Oregon Health & Science University, Portland
Ap rekriteFaz 1/2
Laj 18 a 70 · Tout sèks · Mizajou Aug 13, 2026 · NCT06359041

Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

  • Site Number - 1031, Eugene
Ap rekriteFaz 3
Laj 18 a 80 · Tout sèks · Mizajou Jul 30, 2026 · NCT07039916

KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis

  • Oregon Health & Science University, Portland
Ap rekriteFaz 2/3
Laj 18 a 75 · Tout sèks · Mizajou Jul 29, 2026 · NCT06193889

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

  • Oregon Health & Science University/Doernbecher Children's Hospital, Portland
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Jul 6, 2026 · NCT01351545

Study of Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis

  • Oregon Health Sciences University, Portland
Ap rekriteFaz 1
Laj 18 a 70 · Tout sèks · Mizajou Jun 30, 2026 · NCT06201416

A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases

  • Oregon Health & Science University (OHSU), Portland
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Feb 25, 2026 · NCT06626919

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.